Optimization of an exogenous metabolic activation system for FETAX. I. Post-isolation rat liver microsome mixtures

Drug and Chemical Toxicology

Volumn 24, Issue 2, 2001, Pages 103-115

  Fort, D J ^a   Rogers, R L ^a   Stover, E L ^a   Finch, R A ^a  

^a NONE   (United States)

Author keywords

Developmental toxicity; FETAX; Metabolic activation system; Xenopus

Indexed keywords

AROCLOR 1254; BETA NAPHTHOFLAVONE; COUMARIN; CYCLOPHOSPHAMIDE; ISONIAZID; N (2 FLUORENYL)ACETAMIDE; PHENOBARBITAL; TRICHLOROETHYLENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLASTULA; CELL DIFFERENTIATION; CONGENITAL MALFORMATION; CONTROLLED STUDY; DISEASE SEVERITY; EMBRYO; EMBRYO GROWTH; FROG; LC 50; LIVER MICROSOME; MALE; METABOLIC ACTIVATION; NONHUMAN; PH; PRENATAL DEVELOPMENT; PRENATAL EXPOSURE; RAT;

2-ACETYLAMINOFLUORENE; ABNORMALITIES, DRUG-INDUCED; ANIMALS; AROCLOR 1254; BETA-NAPHTHOFLAVONE; BIOTRANSFORMATION; COUMARINS; CYCLOPHOSPHAMIDE; EMBRYO; ISONIAZID; MICROSOMES, LIVER; PHENOBARBITAL; RATS; TOXICITY TESTS; TRICHLOROETHYLENE; XENOPUS LAEVIS;

ANIMALIA; ANURA; XENOPUS LAEVIS;

EID: 0035021352     PISSN: 01480545     EISSN: None     Source Type: Journal    
DOI: 10.1081/DCT-100102604     Document Type: Article

References (29)

1. Induction of microsomal cytochrom P-450 enzymes: The first Bernard B Brodie lecture at Pennsylvania State University
2. Teratogenicity testing in vitro: Status of validation studies
3. Drug metabolizing enzymes in Drosophila melanogastor: Teratogenicity of cyclophosphamide in vitro
4. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test
5. Development of a metabolic activation system for the frog embryo teratogenesis assay: Xenopus (FETAX)
6. Regulation of cytochrome P-450j, a high affinity N-nitrosodimethylamine demethylase, in rat hepatic microsomes
7. Analysis of the Mechanism of Isoniazid-Induced Developmental Toxicity with Frog Embryo Teratogenesis Assay: Xenopus (FETAX)
8. Evaluation of the developmental toxicity of five compounds with the frog embryo teratogenesis assay - Xenopus (FETAX) and a metabolic activation system
9. Evaluation of the developmental toxicity of nicotine and cotinine with frog embryo teratogenesis assay: Xenopus (FETAX)
10. Use of frog embryo teratogenesis assay - Xenopus and an exogenous metabolic activation system to evaluate the developmental toxicity of diphenylhydantoin
11. Quantitative comparison on toxicity of anti-cancer agents in mouse, rat, dog, monkey, and man
12. A rapid sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
13. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction
14. Effects of methylmercury hydroxide on rat liver microsomal enzymes
15. Stability of activating systems for in vitro mutagenesis assays: Enzyme activity and activating ability following long-term storage at -85°C
16. Development of a reconstituted water medium and initial validation of FETAX
17. Trimmed Spearman-Karber method for estimating median lethal concentrations in toxicity bioassays
18. Developmental toxicity testing with FETAX: Evaluation of five validation compounds
19. Cyclophosphamide teratogenesis: A review
20. Interlaboratory validation of an exogenous metabolic activation system for frog embryo teratogenesis assay - Xenopus (FETAX)
21. Assessment of the developmental toxicity of ascorbic acid, sodium selenate, coumarin, serotonin, and 13-cis retinoic acid tested using FETAX
22. Evaluation of the Developmèntal Toxicities of Coumarin, 4-Hydroxycoumarin, and 7-Hydroxycoumarin Using FETAX
23. Evaluation of the development toxicity of benzo(α)pyrene and 2-acetylaminofluorene using Xenopus: Modes of biotransformation
24. Evaluation of the developmental toxicity of TCE and detoxificatin metabolites using Xenopus
25. The response of the FETAX model to mammalian teratogens